Affiliation:
1. Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi-110062, India
2. Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, AL-35294, United States
Abstract
Background:
Chlorophytum comosum, popularly known as Spider Ivy, is used as a medicinal plant in
traditional Chinese medicine, however, its detailed chemical composition and biological activity are yet
unexplored.
Objective:
To carry out the phytochemical investigation on different parts of Chlorophytum comosum using GCMS/
LC-ESI-MS and evaluation of its antioxidant, hemolytic and antiproliferative potential on breast cancer
(MCF-7), lung cancer (A549, H1299) and normal lung (L-132) cell lines.
Methods:
Chemical constituents from aqueous roots and leaves extracts were identified using LC-ESI-MS/GCMS.
The identified compounds were annotated based on the match of mass spectra with the literature using NIST
14 and METLIN databases. Antioxidant activity was studied using DPPH, FRAP and TPC assays. The
antiproliferative effects of ethanolic roots and leaves extracts of Chlorophytum comosum were measured by MTT
assay on breast cancer (MCF-7), lung cancer (A549 & H1299) and normal lung (L-132) cell lines. The toxicity
studies of the extracts were carried out using Hemolysis assay.
Results:
GC-MS analysis identified 34 metabolites in roots and 17 from leaves, while 17 compounds from roots
and 7 from leaves were detected by LC-ESI-MS. Significant antiproliferative effects were observed on the A549
and MCF-7 cancer cell lines with IC50 values ranging from 56.86 μg/ml to 68.68 μg/ml while no marked
response was observed against normal cell line L-132.
Conclusion:
Our study represents the first report on the detailed chemical composition and antiproliferative
potential of Chlorophytum comosum against lung and breast cancer cell lines.
Publisher
Bentham Science Publishers Ltd.
Subject
Cancer Research,Pharmacology,Molecular Medicine
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献